| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197344 Human Leukocyte Antigen (HLA)-based HIV vaccine |
| 10/07/2004 | US20040197341 Therapeutic process for p. aeruginosa infections using macrolide antibiotics |
| 10/07/2004 | US20040197340 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 10/07/2004 | US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus |
| 10/07/2004 | US20040197330 Binding to lecithin receptor; viricides |
| 10/07/2004 | US20040197307 Mixture of human interferons |
| 10/07/2004 | US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses |
| 10/07/2004 | US20040197289 Kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 10/07/2004 | CA2529311A1 Compounds for the treatment of flaviviridae infections |
| 10/07/2004 | CA2520533A1 Allicin |
| 10/07/2004 | CA2520257A1 Long acting biologically active conjugates |
| 10/07/2004 | CA2520254A1 Treatment of viral infections |
| 10/07/2004 | CA2520138A1 Improved fc fusion proteins |
| 10/07/2004 | CA2520009A1 Oxamide derivatives useful as raf-kinase inhibitors |
| 10/07/2004 | CA2519962A1 Novel galenical system for active transport, method for preparation and use |
| 10/07/2004 | CA2519922A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | CA2518823A1 Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 10/07/2004 | CA2517673A1 Improved vaccines for preventing viral infection |
| 10/06/2004 | EP1464673A2 Polyanhydrides with biologically active degradation products |
| 10/06/2004 | EP1463949A2 Diagnostics and vaccines for mycobacterium paratuberculosis infections |
| 10/06/2004 | EP1463819A1 Hiv-1 virus tat-protein mutants |
| 10/06/2004 | EP1463812A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 10/06/2004 | EP1463811A2 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 10/06/2004 | EP1463761A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 10/06/2004 | EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463743A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate |
| 10/06/2004 | EP1463735A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 10/06/2004 | EP1463731A1 Dibenzodiazepine derivates, their preparation and use |
| 10/06/2004 | EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463704A1 Antibacterial compounds |
| 10/06/2004 | EP1463522A1 Human antipneumococcal antibodies from non-human animals |
| 10/06/2004 | EP1463520A2 Immunisation against chlamydia trachomatis |
| 10/06/2004 | EP1463519A2 Vaccine |
| 10/06/2004 | EP1463513A1 Stabilized brivudine topical formulations |
| 10/06/2004 | EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | EP1463500A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
| 10/06/2004 | EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases |
| 10/06/2004 | EP1463497A2 Treating muscle wasting with selective androgen receptor modulators |
| 10/06/2004 | EP1463487A1 Liposomal delivery of vitamin e based compounds |
| 10/06/2004 | EP1463479A2 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 10/06/2004 | EP1463408A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 10/06/2004 | EP1349561B1 Essential oils for the local treatment of herpes labialis |
| 10/06/2004 | EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof |
| 10/06/2004 | EP1272652B1 Herpes viruses for immune modulation |
| 10/06/2004 | EP1255548A4 Use of thiostrepton as an anti-mycobacterial agent |
| 10/06/2004 | EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 10/06/2004 | EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 10/06/2004 | EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 10/06/2004 | EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1144414B1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 10/06/2004 | EP1135163B1 Topical compositions comprising ascomycins |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1051433B1 Antimicrobial peptides |
| 10/06/2004 | EP1012295B1 Alphavirus rna replicon systems |
| 10/06/2004 | EP0977588B1 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 10/06/2004 | EP0971739B1 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 10/06/2004 | EP0941240B1 New picornaviruses, vaccines and diagnostic kits |
| 10/06/2004 | EP0904075B1 Method for treating viral infections |
| 10/06/2004 | EP0876498B1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv |
| 10/06/2004 | EP0868425B1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments |
| 10/06/2004 | CN1535314A Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
| 10/06/2004 | CN1535312A PUFA polyketide synthase systems and uses thereof |
| 10/06/2004 | CN1535278A Process for preparation of L-ribavirin |
| 10/06/2004 | CN1535277A Process for preparation of L-ribavirin |
| 10/06/2004 | CN1535275A Prodrugs of 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1535158A Vaccines comprising aluminium adjuvants and histidine |
| 10/06/2004 | CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl} |
| 10/06/2004 | CN1535151A Novel anti-infectives |
| 10/06/2004 | CN1535149A Topical application of thiazolyl amides |
| 10/06/2004 | CN1535140A Microparticle compositions and method for manufacture thereof |
| 10/06/2004 | CN1534044A Recombination human interferon alpha 8 polypeptide coding cDNA sequence preparation method and application |
| 10/06/2004 | CN1533808A Composition for treating coronavirus infection and SARS and method |
| 10/06/2004 | CN1533807A High dosage recombination human alpha interferon oral tablet and its manufacturing method |
| 10/06/2004 | CN1533806A Liver cell growing promotor injection and its preparation method and application |
| 10/06/2004 | CN1533788A Medicine for treating virus diarrhea and its preparation method |
| 10/06/2004 | CN1533784A Chinese medicinal composition for treating animal virus zymosis |
| 10/06/2004 | CN1533779A New medicine for treating beriberi |
| 10/06/2004 | CN1533778A New type microbicide for preventing human Aids virus and other pathogen propagation |
| 10/06/2004 | CN1533776A Application of N-acetly glucosamine in the preparation of medicine for treating local injury and full body syndrome due to virus or bacterial infestation |
| 10/06/2004 | CN1533774A Application of N-acetylglucosamine in the preparation of medicine for treating and contrlling non specific inflammation due to physicochemical factor |
| 10/06/2004 | CN1533766A Use and preparation method of medicine lanthanum nitrate for inhibiting human Aids virus and other sexual propagation disease pathogen propagation through procreating channel |
| 10/06/2004 | CN1169824C Polytype gene of MXA protein and application thereof |
| 10/06/2004 | CN1169810C Peptide nucleic acid derivatives and preparing process, intermediate for preparing them and medicinal composition containing them |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/06/2004 | CN1169802C Corter pseudolaricis acetic acid composition and its preparing process |
| 10/06/2004 | CN1169798C Novel diazo alcoholic antifungal compound and its preparing process |
| 10/06/2004 | CN1169797C Antiviral phrimidinedione derivatives and process for preparation thereof |
| 10/06/2004 | CN1169793C Process for producing bis (4-amino-1-pyridine) paraffins |
| 10/06/2004 | CN1169570C Medicine for treating acute and chronic hepatitis B |
| 10/06/2004 | CN1169567C Medicine for external application for curing infantile pneumonia and preparing method thereof |